Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Long-Term Clinical Outcomes of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory ALL.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 29, 2026
Breaking Access Barriers to Autologous Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy in Hematologic Malignancies-an ASTCT-NMDP ACCESS Initiative.
Journal: Transplantation and cellular therapy
Published: December 19, 2025
Breaking Access Barriers to Autologous Stem Cell Transplant and Chimeric Antigen Receptor T Cell therapy in Hematological Malignancies - an ASTCT-NMDP ACCESS Initiative.
Journal: Transplantation and cellular therapy
Published: December 19, 2025
Identification of Distinct Subtypes in Immune Tolerance after Hematopoietic Cell Transplantation Using the Prospective ABLE1.0 Pediatric Study Cohort.
Journal: Transplantation and cellular therapy
Published: April 07, 2025
Distinct biological subtypes of chronic GVHD after pediatric hematopoietic cell transplantation.
Journal: Blood
Published: January 31, 2025
Proceedings of the 2024 Third Annual ASTCT-NMDP ACCESS Initiative Workshop.
Journal: Transplantation and cellular therapy
Published: August 30, 2024
Sociodemographic Factors Influencing Access to Chimeric Antigen T-Cell Receptor Therapy for Patients With Non-Hodgkin Lymphoma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: July 10, 2024
CAR T-Cell Immunotherapy in Minority Patients with Lymphoma.
Journal: NEJM evidence
Published: May 22, 2024
Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol.
Journal: Blood advances
Published: October 24, 2023
Proceedings of the 2023 Second Annual ASTCT-NMDP ACCESS Initiative Workshop.
Journal: Transplantation and cellular therapy
Published: September 26, 2023
Last Updated: 09/26/2026